menu
    • menu

    Company profile for Orphalan

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Orphalan we identify, develop, and provide access to innovative treatments for patients with rare diseases to make a positive and meaningful difference. We work together by, listening to patients and putting them first, enables us to provide treatments and services that work for them. We use a global network of experts including scientists, academic institutions and companies with innovative technologies to provide support...
    At Orphalan we identify, develop, and provide access to innovative treatments for patients with rare diseases to make a positive and meaningful difference. We work together by, listening to patients and putting them first, enables us to provide treatments and services that work for them. We use a global network of experts including scientists, academic institutions and companies with innovative technologies to provide support to patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OrphalanFrance Flag
    Country
    Country
    France
    Address
    Address
    226 Boulevard Voltaire 75011 Paris
    Telephone
    Telephone
    +33 (0)1 42 49 82 64
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.orphalan.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/orphalan/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Orphalan Announces Acquisition Of Orphelia Pharma
    Orphalan Announces Acquisition Of Orphelia Pharma

    12 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orphalan-announces-acquisition-of-orphelia-pharma-302640048.html

    PR NEWSWIRE
    12 Dec 2025
    Share Share
    Orphalan partners with MAP International and Wilson Disease Assoc
    Orphalan partners with MAP International and Wilson Disease Assoc

    27 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/27/3106373/0/en/Orphalan-Partners-with-MAP-International-and-the-Wilson-Disease-Association-to-Provide-Life-Changing-Medicine-to-Underserved-Communities.html

    GLOBENEWSWIRE
    27 Jun 2025
    Share Share
    Orphalan Becomes First European Firm In China's Wilson Market
    Orphalan Becomes First European Firm In China's Wilson Market

    07 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orphalan-becomes-the-first-european-company-to-enter-in-chinas-wilson-disease-market-302395032.html

    PR NEWSWIRE
    07 Mar 2025
    Share Share
    Orphalan announces NMPA™s approval of its trientine tetrahydrochloride product
    Orphalan announces NMPA™s approval of its trientine tetrahydrochloride product

    18 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/18/2811263/0/en/Orphalan-announces-China-NMPA-s-approval-of-its-trientine-tetrahydrochloride-product-for-the-treatment-of-Wilson-disease.html

    GLOBENEWSWIRE
    18 Jan 2024
    Share Share
    Orphalan announces US commercial launch of Cuvrior
    Orphalan announces US commercial launch of Cuvrior

    20 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/20/2650813/0/en/Orphalan-announces-US-commercial-launch-of-Cuvrior-for-the-treatment-of-Wilson-disease.html

    GLOBENEWSWIRE
    20 Apr 2023
    Share Share
    Orphalan announces publication of results from the CHELATE trial
    Orphalan announces publication of results from the CHELATE trial

    29 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/30/2525726/0/en/Orphalan-announces-publication-of-results-from-the-CHELATE-trial-in-The-Lancet-Gastroenterology-Hepatology.html

    GLOBENEWSWIRE
    29 Sep 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search